Paula Silva-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Paula Silva-Rodríguez has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Piñeiro-Ces
Department of Ophthalmology, University Hospital of Santiago de Compostela, Ramon Baltar S/N, 15706 Santiago de Compostela, Spain
2 shared publications - Manuel F. Bande
Department of Ophthalmology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain
2 shared publications - María Pardo
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Av Monforte de Lemos 3-5, 28029 Madrid, Spain; Grupo Obesidómica, Área de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela/SERGAS, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain
2 shared publications - Nerea Lago-Baameiro
Obesidomic Group, Endocrinology Area, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS)/SERGAS, Santiago de Compostela, Spain
2 shared publications Ana Furão Rodrigues
Department of Internal Medicine II, Centro Hospitalar Universitário Lisboa Norte, E.P.E., Lisbon, Portugal
1 shared publicationAna Oliveira Pedro
Department of Internal Medicine II, Centro Hospitalar Universitário Lisboa Norte, E.P.E., Lisbon, Portugal
1 shared publication
Latest Publications
- 2 September 2026
- Published by Springer Nature
- p. 369-385
Approach to Neurodevelopmental Disorders from Clinical Genetics
- 2 September 2026
- Published by Springer Nature
- p. 369-385
Approach to Neurodevelopmental Disorders from Clinical Genetics
- Open Access
- 6 April 2023
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 10 (4) , 003793
COVID-19 related acalculous Groove Pancreatitis
Introduction: Groove pancreatitis is a rare form of chronic pancreatitis. Its radiological diagnosis is challenging and it can be difficult to distinguish from pancreaticoduodenal malignancy. Case description: A 64-year-old woman was admitted to our internal medicine ward after she contracted severe COVID-19 pneumonia requiring mechanical ventilation. She presented with right upper abdominal pain, and a CT scan showed pancreaticoduodenal inflammatory tissue; malignancy was ruled out. Conclusion: Diagnosing groove pancreatitis is challenging and malignancy must be quickly excluded. No cases of COVID-19-associated groove pancreatitis have been previously described.
- 6 April 2023
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 10 (4) , 003793
Open AccessCOVID-19 related acalculous Groove Pancreatitis
Introduction: Groove pancreatitis is a rare form of chronic pancreatitis. Its radiological diagnosis is challenging and it can be difficult to distinguish from pancreaticoduodenal malignancy. Case description: A 64-year-old woman was admitted to our internal medicine ward after she contracted severe COVID-19 pneumonia requiring mechanical ventilation. She presented with right upper abdominal pain, and a CT scan showed pancreaticoduodenal inflammatory tissue; malignancy was ruled out. Conclusion: Diagnosing groove pancreatitis is challenging and malignancy must be quickly excluded. No cases of COVID-19-associated groove pancreatitis have been previously described.
- 28 January 2022
- Published by Elsevier
- p. 177-210
Noncoding RNAs in intraocular tumor patients
- 17 December 2021
- Published by SAGE Publications in Tumori Journal
- Vol. 109 (1) , 47-53
PARK7/DJ-1 inhibition decreases invasion and proliferation of uveal melanoma cells
Introduction: PARK7/DJ-1 is an oncogene that is associated with tumorigenesis in many cancers. Recent studies have demonstrated the importance of DJ-1 in the origin and development of uveal melanoma (UM). We present an analysis of the role of the DJ-1 protein in UM cells, especially in its effect on proliferation and migration. Methods: UM cells from a primary tumor, Mel 270, and its liver metastasis, OMM2.5, were transfected with lentiviral-delivered shRNA against PARK7/DJ-1. Evaluation of cell migration and proliferation was performed using the xCELLigence real-time cell analyzer (RTCA). The effect of DJ-1 inhibition on the PTEN-Akt signaling pathway was also studied by immunoblotting. Results: The silencing of PARK7/DJ-1 oncoprotein expression produced a significant decrease of phosphorylated Akt (S473) in Mel270 and in metastatic OMM2.5 UM cells with no alteration on tumor suppressor PTEN expression. The diminution of PARK7/DJ-1 expression significantly inhibited real-time proliferation and invasion of Mel270 and OMM2.5 and the invasion potential of the metastatic cells. Conclusion: DJ-1 appears to play a key role on the PTEN/Akt pathway in UM. DJ-1 inhibition appears to have a negative effect on proliferation and invasion of UM cells. This suggests DJ-1 as a potential therapeutic target in UM.
- 17 December 2021
- Published by SAGE Publications in Tumori Journal
- Vol. 109 (1) , 47-53
PARK7/DJ-1 inhibition decreases invasion and proliferation of uveal melanoma cells
Introduction: PARK7/DJ-1 is an oncogene that is associated with tumorigenesis in many cancers. Recent studies have demonstrated the importance of DJ-1 in the origin and development of uveal melanoma (UM). We present an analysis of the role of the DJ-1 protein in UM cells, especially in its effect on proliferation and migration. Methods: UM cells from a primary tumor, Mel 270, and its liver metastasis, OMM2.5, were transfected with lentiviral-delivered shRNA against PARK7/DJ-1. Evaluation of cell migration and proliferation was performed using the xCELLigence real-time cell analyzer (RTCA). The effect of DJ-1 inhibition on the PTEN-Akt signaling pathway was also studied by immunoblotting. Results: The silencing of PARK7/DJ-1 oncoprotein expression produced a significant decrease of phosphorylated Akt (S473) in Mel270 and in metastatic OMM2.5 UM cells with no alteration on tumor suppressor PTEN expression. The diminution of PARK7/DJ-1 expression significantly inhibited real-time proliferation and invasion of Mel270 and OMM2.5 and the invasion potential of the metastatic cells. Conclusion: DJ-1 appears to play a key role on the PTEN/Akt pathway in UM. DJ-1 inhibition appears to have a negative effect on proliferation and invasion of UM cells. This suggests DJ-1 as a potential therapeutic target in UM.